Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Other Non-Current Liabilities (2020 - 2025)

Cresco Labs' Other Non-Current Liabilities history spans 6 years, with the latest figure at $5.8 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 24.83% year-over-year to $5.8 million; the TTM value through Dec 2025 reached $5.8 million, down 24.83%, while the annual FY2025 figure was $5.8 million, 24.83% down from the prior year.
  • Other Non-Current Liabilities reached $5.8 million in Q4 2025 per CRLBF's latest filing, down from $7.7 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $20.2 million in Q4 2023 to a low of $5.8 million in Q4 2025.
  • Average Other Non-Current Liabilities over 5 years is $10.7 million, with a median of $7.7 million recorded in 2024.
  • Peak YoY movement for Other Non-Current Liabilities: skyrocketed 84.27% in 2022, then plummeted 61.73% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $7.0 million in 2021, then surged by 84.27% to $12.9 million in 2022, then skyrocketed by 56.67% to $20.2 million in 2023, then tumbled by 61.73% to $7.7 million in 2024, then dropped by 24.83% to $5.8 million in 2025.
  • Per Business Quant, the three most recent readings for CRLBF's Other Non-Current Liabilities are $5.8 million (Q4 2025), $7.7 million (Q4 2024), and $20.2 million (Q4 2023).